- Home
- TOI vs PYPD Comparison
TOI vs PYPD Comparison
Compare TOI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- PYPD
- Stock Information
- Founded
- TOI 2007
- PYPD 2008
- Country
- TOI United States
- PYPD Israel
- Employees
- TOI N/A
- PYPD N/A
- Industry
- TOI Medical/Nursing Services
- PYPD Medical/Dental Instruments
- Sector
- TOI Health Care
- PYPD Health Care
- Exchange
- TOI Nasdaq
- PYPD Nasdaq
- Market Cap
- TOI 266.8M
- PYPD 36.0M
- IPO Year
- TOI N/A
- PYPD 2020
- Fundamental
- Price
- TOI $3.43
- PYPD $3.66
- Analyst Decision
- TOI Strong Buy
- PYPD Strong Buy
- Analyst Count
- TOI 1
- PYPD 5
- Target Price
- TOI $6.00
- PYPD $11.40
- AVG Volume (30 Days)
- TOI 2.5M
- PYPD 175.1K
- Earning Date
- TOI 08-12-2025
- PYPD 08-13-2025
- Dividend Yield
- TOI N/A
- PYPD N/A
- EPS Growth
- TOI N/A
- PYPD N/A
- EPS
- TOI N/A
- PYPD N/A
- Revenue
- TOI $403,152,000.00
- PYPD N/A
- Revenue This Year
- TOI $23.95
- PYPD N/A
- Revenue Next Year
- TOI N/A
- PYPD N/A
- P/E Ratio
- TOI N/A
- PYPD N/A
- Revenue Growth
- TOI 17.64
- PYPD N/A
- 52 Week Low
- TOI $0.13
- PYPD $2.30
- 52 Week High
- TOI $3.78
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- TOI 70.54
- PYPD 65.03
- Support Level
- TOI $2.95
- PYPD $3.30
- Resistance Level
- TOI $3.77
- PYPD $3.87
- Average True Range (ATR)
- TOI 0.28
- PYPD 0.14
- MACD
- TOI 0.14
- PYPD 0.01
- Stochastic Oscillator
- TOI 94.93
- PYPD 86.84
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.